Accelerating Innovation at Leica Biosystems

Strengthening Secular Growth Drivers GROWTH SHIFT IN DRIVERS INCREASING MEDICINE TO FOCUS ON BIOLOGICS GENOMIC MEDICINE VACCINES & HGM THERAPEUTICS INVESTMENTS IN IN RESPONSE TO COVID-19 BIOPROCESSING EXAMPLES +50% INCREASE IN mAbs IN DEVELOPMENT OVER LAST 5 YEARS +10X INCREASE IN CELL & GENE THERAPIES IN DEVELOPMENT SINCE 2015 1/3rd SHARE OF GLOBAL POPULATION RECEIVING AT LEAST ONE VACCINE DOSE +25% ANNUAL GROWTH IN CHINA BIOLOGICS SPENDING 2012-2021 Expect Cytiva core growth to re-rate higher vs expectations due to internal execution & strengthening growth drivers DANAHER

View entire presentation